#7cbde1_Small_Sep-Oct 2024 DRA Journal Cover

The latest DRA Journal issue showcases Asia's dental innovation, featuring Thailand's pioneering stem cell research, advanced clinical techniques like 3D-printed dentures for senior patients and digital workflows for implant restorations, a review of top Asian dental startups, and strategies for improving dental practice culture.

>> FlipBook Version (Available in English)

>> Mobile-Friendly Version (Available in Multiple Languages)

Click here to access Asia's first Open-Access, Multi-Language Dental Publication

FDA Warns Pregnant Women Over Medicine Use

TAIWAN: According to an article published by the Taipei Times (https://www.taipeitimes.com/), women should be cautious when using medical drugs during pregnancy, although refraining from all medications is not necessary, the Food and Drug Administration (FDA) has advised. At a news conference held on August 21, Lin Wei-chen (林委正), head of the Medical Devices and Cosmetics Division, emphasized the need for careful management of medication use during pregnancy due to the potential impact on fetal health.

“Many substances can breach the placenta barrier, affecting fetal health,” Lin said. He added that these drugs could lead to severe developmental issues such as deformities in the cardiovascular or nervous systems, as well as malformations in the brain, limbs, or face.

Balancing Risks and Benefits of Medication

Pregnant women face a challenging decision in deciding whether to use medications. Lin stressed that taking medical drugs during pregnancy is a matter of “balancing risks and rewards” and that such decisions require a thorough assessment by medical experts. He urged expecting mothers to consult healthcare providers to evaluate the potential impacts of medication use on both the mother and the fetus.

This perspective was supported by Lee Wen-fang (李汶芳), an obstetrician, who pointed out that medicinal substances pose the highest risk of causing fetal deformities during the critical stage of organ development, which takes place between the third and eighth weeks of pregnancy. During this period, particular care is needed to minimize exposure to harmful substances.

Safe Medication Options for Pregnant Women

Although caution is advised, Lee made it clear that pregnant women do not need to avoid all medications. She stated that various prescription drugs could still be used safely to alleviate pregnancy-related discomfort, such as gastric motility-stimulating medicines to manage nausea when other methods like hydration, dietary changes, and sleep adjustments prove ineffective.

Additionally, Lee noted that pregnancy tends to weaken the immune system, making women more susceptible to illnesses. For this reason, they may be prescribed medication for ailments that otherwise might not require drugs, such as otitis media and sinus infections. Penicillin-based substances, for example, are commonly used to treat such infections and are often prescribed as a safer alternative to invasive dental procedures during pregnancy.

Managing Chronic Conditions During Pregnancy

Lee emphasized the importance of managing chronic illnesses during pregnancy. She advised women who are dealing with long-term health conditions to communicate their situation to obstetricians to ensure appropriate adjustments to their medication dosages. “Many people have problems after stopping their medication without consulting a doctor,” Lee said, warning against making unilateral decisions regarding chronic medication.

The use of topically applied drugs and ointments to treat skin irritations during pregnancy is another common approach, with Lee explaining that these options provide relief without posing significant risks to fetal health.

Expert Guidance is Key

The advice provided by the FDA underscores the importance of consulting medical experts when dealing with health issues during pregnancy. While certain drugs can have severe consequences for fetal development, others may be used safely to improve the comfort and health of the mother. The key, according to Lin and Lee, is for pregnant women to seek out personalized medical advice, ensuring a careful balance between the benefits and risks of any medication.

The original article by Jonathan Chin, along with contributions from the Central News Agency (CNA), emphasizes the FDA’s message: pregnancy is a delicate period, and women should seek expert guidance in making decisions about medication.

The information and viewpoints presented in the above news piece or article do not necessarily reflect the official stance or policy of Dental Resource Asia or the DRA Journal. While we strive to ensure the accuracy of our content, Dental Resource Asia (DRA) or DRA Journal cannot guarantee the constant correctness, comprehensiveness, or timeliness of all the information contained within this website or journal.

Please be aware that all product details, product specifications, and data on this website or journal may be modified without prior notice in order to enhance reliability, functionality, design, or for other reasons.

The content contributed by our bloggers or authors represents their personal opinions and is not intended to defame or discredit any religion, ethnic group, club, organisation, company, individual, or any entity or individual.

Leave a Reply

Your email address will not be published. Required fields are marked *